Literature DB >> 1246330

Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.

R S Sherwin, M Fisher, R Hendler, P Felig.   

Abstract

Glucagon was infused to maintain plasma concentrations three to six times the basal level (300 to 600 pg per milliliter) into 16 normal and seven non-diabetic obese subjects. Hyperglucagonemia caused only a transient rise of 5 to 10 mg per 100 ml in basal glucose levels and had no effect on oral glucose tolerance or plasma insulin. In three patients with adult and two with juvenile-onset diabetes on maintenance insulin, hyperglucagonemia maintained for two to four days caused no change in plasma glucose of ketone concentration. In contrast, in nine insulin-withdrawn patients the glycemic response to hyperglucagonemia was five to 15 times greater (P less then 0.05) than in normal controls. Hyperglucagonemia does not cause glucose intolerance in normal subjects or bring about deterioration of diabetic control when insulin is available. Glucagon in the insulin-deprived patient can worsen the diabetic state. These findings suggest the primary role of insulin deficiency in the diabetogenic action of glucagon.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1246330     DOI: 10.1056/NEJM197602262940901

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  46 in total

1.  Ectopic expression of glucagon receptor in skeletal muscles improves glucose homeostasis in a mouse model of diabetes.

Authors:  A Maharaj; L Zhu; F Huang; H Qiu; H Li; C Y Zhang; T Jin; Q Wang
Journal:  Diabetologia       Date:  2012-02-09       Impact factor: 10.122

2.  Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats.

Authors:  V Soman; P Felig
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

3.  The effect of intraportal and peripheral infusions of glucagon on insulin and glucose concentrations and glucose tolerance in normal man.

Authors:  J J Holst; O G Madsen; J Knop; A Schmidt
Journal:  Diabetologia       Date:  1977-09       Impact factor: 10.122

4.  TASK-1 Potassium Channels Limit Pancreatic α-Cell Calcium Influx and Glucagon Secretion.

Authors:  Prasanna K Dadi; Brooke Luo; Nicholas C Vierra; David A Jacobson
Journal:  Mol Endocrinol       Date:  2015-04-07

5.  Effects of short-term intensive glycemic control on insulin, glucagon, and glucagon-like peptide-1 secretion in patients with Type 2 diabetes.

Authors:  M Shimodaira; Y Muroya; N Kumagai; K Tsuzawa; K Honda
Journal:  J Endocrinol Invest       Date:  2013-04-12       Impact factor: 4.256

6.  Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM.

Authors:  S Dinneen; A Alzaid; D Turk; R Rizza
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

7.  Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of type 1 diabetes.

Authors:  Kitt Falk Petersen; Thomas B Price; Raynald Bergeron
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

8.  Effect of glucagon on glucose production during insulin deficiency in the dog.

Authors:  A D Cherrington; W W Lacy; J L Chiasson
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

9.  Persistent metabolic abnormalities in diabetes in the absence of glucagon.

Authors:  A J Barnes; S R Bloom; K Mashiter; K G Alberti; P Smythe; D Turnell
Journal:  Diabetologia       Date:  1977-01       Impact factor: 10.122

10.  Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.

Authors:  N Eigler; L Saccà; R S Sherwin
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.